MARKET

MNTA

Momenta Pharm
MNTA
NASDAQ
Delisted
P/E
P/S
P/B
MARKET CAP
-17.9732
190.03
15.74
6,243,294,955.52
News
Financial
Releases
Corp Actions
Analysis
Profile
Merger Arbitrage - Q3 2020 Ends With A Big Bang
Merger activity increased significantly last week with ten new deals announced.The merger of WPX Energy (WPX) and Devon Energy Corporation (DVN).Morgan Stanley (MS) completes the acquisition of E*TRADE Financial Corporation (ETFC).
Seekingalpha · 10/09 04:58
The Daily Biotech Pulse: Amag Spikes On Takeover Rumors, Zosano Wilts On Regulatory Setback, Pulmonx Makes Wall Street Debut
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Sept. 30)
Benzinga · 10/01 12:18
The Daily Biotech Pulse: Eton Snags Second FDA Nod For Month, Vaccine Updates from Moderna, CureVac
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Sept. 29)
Benzinga · 09/30 11:45
The Daily Biotech Pulse: FDA Nod For Pfizer, Sorrento's COVID-19 Antibody Animal Data, Orphazyme's Wall Street Debut
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Sept. 28)
Benzinga · 09/29 11:47
The Week Ahead In Biotech: FDA Decisions For Mesoblast And Eton, Coronavirus Vaccine Updates
Biotech stock reversed course last week, dragged lower by the broader market weakness.
Benzinga · 09/26 18:40
Chesapeake Utilities to Join S&P SmallCap 600
Chesapeake Utilities Corp (NYSE:CPK) will replace Momenta Pharmaceuticals Inc (NASD:MNTA) in the S&P; SmallCap 600 effective prior to the opening of trading on Thursday, October 1. S&P; 500 constituent Johnson & Johnson (NYSE: JNJ) is acquiring Momenta Pharmaceuticals in a deal expected to be completed
PR Newswire · 09/25 21:47
Chesapeake Utilities +1.4% on move into SmallCap 600
Chesapeake Utilities (CPK) is up 1.4% after hours following news that it's moving into the S&P SmallCap 600. It's replacing Momenta Pharmaceuticals (MNTA), set to be acquired by S&P 500
Seekingalpha · 09/25 21:32
STOCKHOLDER ALERT: Monteverde & Associates Continues its Investigation into the Following Merger
NEW YORK, NY / ACCESSWIRE / September 23, 2020 / Juan Monteverde, founder and managing partner at Monteverde & Associates PC, a national securities firm headquartered at the Empire State Building in New York City, is investigating: * Akcea Therapeutics, Inc.
ACCESSWIRE · 09/23 18:35
More
Forecast
EPSBVPSCFPS
Actual (USD)
Estimate (USD)
Income StatementMore
Net IncomeTotal RevenueOperating Income
Net Income (USD)
YoY (%)
Balance SheetMore
Total Assets (USD)
Total Liabilities (USD)
Debt to Asset (%)
Cash FlowMore
OperatingInvestingFinancing
Operating (USD)
YoY (%)
Learn about the latest financial forecast of MNTA. Analyze the recent business situations of Momenta Pharm through EPS, BVPS, FPS, and other data. This information may help you make smarter investment decisions.
Analyst Rating

Based on 5 analysts

Hold

Disclaimer: The analysis information is for reference only and does not constitute an investment recommendation.

Analyst Price Target
The average MNTA stock price target is 52.50 with a high estimate of 52.50 and a low estimate of 52.50.
EPS
Institutional Holdings
Institutions: 291
Institutional Holdings: 128.42M
% Owned: 107.95%
Shares Outstanding: 118.97M
TypeInstitutionsShares
Increased
97
9.86M
New
75
2.98M
Decreased
58
5.27M
Sold Out
0
0
  • Performance
  • Asset Allocation
  • Dividend History
No Data
Industry
Biotechnology & Medical Research
+3.18%
Pharmaceuticals & Medical Research
+1.72%
Key Executives
Chairman/Independent Director
Bruce Downey
President/Chief Executive Officer/Director
Craig Wheeler
Chief Financial Officer
Young Kwon
Chief Human Resource Officer
Jo-Ann Beltramello
Chief Accounting Officer/Vice President - Finance/Controller
Agnieszka Cieplinska
Chief Scientific Officer
Anthony Manning
General Counsel/Secretary
Alejandra Carvajal
Other
Santiago Arroyo
Other
Ian Fier
Independent Director
Jane Barlow
Independent Director
Georges Gemayel
Independent Director
Steven Gilman
Independent Director
Donna Grogan
Independent Director
Jose-Carlos Gutierrez-Ramos
Independent Director
Elizabeth Stoner
  • Dividends
  • Splits
  • Insider Activity
No Data
Access Level 2 Advance
Nasdaq TotalView
for Free
Get Now

Webull offers kinds of Momenta Pharm stock information, including NASDAQ:MNTA real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, MNTA stock news, and many more online research tools to help you make informed decisions.

You can practice and explore trading MNTA stock methods without spending real money on the virtual paper trading platform.